Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 200
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
4Front Ventures Corp. engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States. The company operates through three segments: Illinois, Massachusetts, and Corporate. It offers flower, pre-rolls, vaporizers, concentrates, edibles, tinctures and soft gels, capsules, and topicals, as well as provides a vertically integrated supply chain to serve both medical and recreational m...
Show more
4Front Ventures Corp. engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States. The company operates through three segments: Illinois, Massachusetts, and Corporate. It offers flower, pre-rolls, vaporizers, concentrates, edibles, tinctures and soft gels, capsules, and topicals, as well as provides a vertically integrated supply chain to serve both medical and recreational markets. The company owns, operates, and manages cultivation and manufacturing facilities and retail centers; sales CBD products to third-party consumers; leases real estate in the state of Washington; and engages in other corporate activities. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 602 428 5337
- Website
- https://4frontventures.com
- Address
- 7010 East Chauncey Lane, Suite 235, Phoenix, United States
Latest news
No headlines yet.
